Methods: In 304 patients with symptoms suggestive of asthma, FeNO and AHR to mannitol or methacholine were measured. A total of 180 who underwent both tests were analyzed and were divided into four groups : low (<25ppb)/high FeNO and with/ without AHR.
Results: FeNO and response to mannitol was measured in 90 patients (group±), and FeNO and response to methacholine in 90 (groupII). Current asthma was diagnosed in 31 (group±, 34.4%) and 37 (groupII, 41.1%). In non-asthmatics, those with low FeNO/-AHR, low FeNO/+AHR, high FeNO/-AHR, high FeNO/+AHR was 78%, 1.7%, 18.6%, 1.7% in group ±; 66%, 0%, 34%, 0% in groupII. Of the asthmatics, 45.2%, 3.2%, 12.9%, 38.7% in group±; 27%, 24.3%, 8.15, 40.6% in groupII, and neither showed significant difference in atopy, duration of asthma, use of inhaled corticosteroid, blood and sputum eosinohils with regard to distribution of FeNO or AHR, except only in FEV1. A significant correlation was observed between log FeNO and log response-dose rate (RDR) mannitol (r=0.411, P=0.024) and also between log FeNO and log RDR methacholine (r=0.336, P=0.042) in only asthma patients.
Conclusions: In asthma patients, the association between FeNO and AHR was stronger in mannitol than in methacholine. However, a significant proportion of patients had high FeNO and no AHR to mannitol and low FeNO and AHR to methacholine.